學術研究成果/Publication
基本資料/Profiles
姓名/Name: 許怡婷 性別/Gender:
英文姓名/
English Name:
Yi-Ting Hsu 英文縮寫/
Abbreviation:
任職單位/
Affiliation:
1.醫學院醫學系學士班神經學科(助理教授) / Department of Neurology (Assistant Professor)
2.中國附醫神經部癲癇科(科(室)主任) / Epilepsy (Director)
Email: 011835@tool.caaumed.org.tw
研究專長/Fields of Specialty
1﹒ 神經退化性疾病診斷治療
2﹒ 癲癇診斷治療
3﹒ 亨丁頓式舞蹈症小鼠病生理機轉研究
 
期刊論文/Journal Paper
(作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
SCI論文 Halliru Zail(HALLIRU ZAILANI)、(Senthil Kumaran Satyanarayanan)、廖偉志(Liao, Wei-Chih)、許怡婷(Yi-Ting Hsu)、(Shih-Yi Huang)、(Piotr Ga?ecki)、蘇冠賓(Kuan-Pin Su)*、張倍禎(Jane Pei-Chen Chang)*,Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Diseases: A Review,Nutrients,2023 Oct,15():4363
Other論文 (Chaur-Jong Hu)、(Ming-Jang Chiu)、(Ming-Chyi Pai)、(Sui-Hing Yan)、(Pei-Ning Wang)、(Pai-Yi Chiu)、(Chin-Hsien Lin)、(Ta-Fu Chen)、(Fu-Chi Yang)、(Kuo-Lun Huang)、許怡婷(Yi-Ting Hsu)、(Yi-Chou Hou)、(Wei-Che Lin)、(Cheng-Hsien Lu)、(Li-Kai Huang)、(Shieh-Yueh Yang)*,Assessment of High Risk for Alzheimer's Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary Study,Journal of Alzheimer's Disease Reports,2021 Oct,5(1):761-770
SCI論文 許怡婷(Yi-Ting Hseu)、(Ya-Gin Chang)、(Yu-Chao Liu)、(Kai-Yi Wang)、(Hui-Mei Chen)、(Ding-Jin Lee)、(Sung-Sen Yang)、蔡崇豪(Chon-Haw Tsai)、(Cheng-Chang Lien)*、(Yijuang Chern)*,Enhanced Na+-K+-2Cl- cotransporter 1 underlies motor dysfunction in Huntington’s disease,MOVEMENT DISORDERS,2019 Jun,34(6):845-857
SCI論文 許怡婷(Yi-Ting Hseu)、張雅晶(Chang YG)、陳儀莊(Chern Y)*,Insights into GABAAergic system alteration in Huntington's disease,Open Biology,2018 Dec,8():
SCI論文 許怡婷(Yi-Ting Hsu)、張雅晶(Ya-Gin Chang)、張敬邦(Ching-Pang Chang)、蕭建靖(Jian-Jing Siew)、陳惠美(Hui-Mei Chen)、蔡崇豪(Tsai, Chon-Haw)、陳儀莊(Yijuang Chern)*,Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease,MOVEMENT DISORDERS,2017 Aug,():
SCI論文 劉崇祥(Chung-Hsiang Liu)、蔡長海(Chang-Hai Tsai)、李采娟(Tsai-Chung Li)、楊玉婉(Yu-Wan Yang)、黃偉師(Wei-Shih Huang)、呂明桂(Ming-Kuei Lu)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、陳冠妃(Kuan-Fei Chen)、許致善(Chih Shan Hsu)、許怡婷(Yi-Ting Hsu(Hseu))、蔡崇豪(Chon-Haw Tsai)、謝慶良(Ching-Liang Hsieh)*,Effects of the traditional Chinese herb Astragalus membranaceus in patients with poststroke fatigue: A double-blind, randomized, controlled preliminary study.,JOURNAL OF ETHNOPHARMACOLOGY,2016 ,():
SCI論文 許怡婷(Yi-Ting Hsu(Hseu))、(Chien-Chang Liao)、張仕妮(Shih-Ni Chang)、楊玉婉(Yu-Wan Yang)、蔡崇豪(Chon-Haw Tsai)、(Ta-Liang Chen)、宋鴻樟(Fung-Chang Sung)*,Increased Risk of Depression in Patients with Parkinson Disease: A Nationwide Cohort Study,AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY,2014 Nov,():
Other論文 (Chun-Chuan Shih)、許怡婷(Yi-Ting Hsu(Hseu))、(Hwang-Huei Wang)、(Ta-Liang Chen)、(Chin-Chuan Tsai)、(Hsin-Long Lane)、(Chun-Chieh Yeh)、宋鴻樟(Fung-Chang Sung)、(Wen-Ta Chiu)、(Yih-Giun Cherng)*、(Chien-Chang Liao)*,Decreased Risk of Stroke in Patients with Traumatic Brain Injury Receiving Acupuncture Treatment: A Population- Based Retrospective Cohort Study,PLoS ONE,2014 Feb,9(2):e89208-e89208
SCI論文 (Mao-chi Jhong)、唐娜櫻(Nou-Ying Tang)、劉崇祥(Chung-Hsiang Liu)、黃偉師(Wei-Shih Huang)、許怡婷(Yi-Ting Hsu(Hseu))、劉彥良(Yen-Liang Liu)、李采娟(Tsai-Chung Li)、謝慶良(Ching-Liang Hsieh)*,Relationship between chinese medicine pattern types, clinical severity, and prognosis in patients with acute cerebral infarct.,Explore-The Journal of Science and Healing,2013 Jul,9(4):226-231
SCI論文 許怡婷(Yi-Ting Hsu(Hseu))、段正仁(Jeng-Ren Duann)、陳君明(Chun-Ming Chen)、楊玉婉(Yu-Wan Yang)、蔡崇豪(Chon-Haw Tsai)*、呂明桂(Ming-Kuei Lu)*,Anatomical and electrophysiological manifestations in a patient with congenital corpus callosum agenesis,BRAIN TOPOGRAPHY,2013 Jan,26(1):171-176
SCI論文 黃虹毓(Hung-Yu Huang)、林剛旭(Kang-Hsu Lin)、陳睿正(Jui-Cheng Chen)、許怡婷(Yi-Ting Hsu(Hseu))*,Type III Sturge-Weber Syndrome With Migraine-like Attacks Associated With Prolonged Visual Aura,HEADACHE,2013 ,():
SCI論文 許致善(Chih Shan Hsu)、吳昱?(Yu-Chin Wu)、呂明桂(Ming-Kuei Lu)、許怡婷(Yi-Ting Hsu(Hseu))、邱尚明(Shang-Ming CHIOU)、蔡崇豪(Chon-Haw Tsai)、陳睿正(Jui-Cheng Chen)*,Tc-99m ECD and Tc-99m TRODAT-1 SPECT in Hashimoto's encephalopathy,CLINICAL NUCLEAR MEDICINE,2012 Apr,37(4):e86-e88
SCI論文 許怡婷(Yi-Ting Hsu(Hseu))、賴欣怡(Hsin-Yi Lai)、(Yao-Chuan Chang)、邱尚明(Shang-Ming CHIOU)、呂明桂(Ming-Kuei Lu)、林裕欽(Yu-Chien Lin)、劉彥良(Yen-Liang Liu)、陳瓊珠(Chiung-Chu Chen)、黃匯淳(Hui-Chun Huang)、(Ting-Fang Chien)、林欣榮(Shinn-Zong Lin)、陳右穎(You-Yin Chen)*、蔡崇豪(Chon-Haw Tsai)*,The Role of the Subthalamic Nucleus in the Preparation of Volitional Movement Termination in Parkinson's Disease,EXPERIMENTAL NEUROLOGY,2012 Jan,233(1):253-263
SCI論文 許怡婷(Yi-Ting Hsu(Hseu))、段正仁(Jeng-Ren Duann)、呂明桂(Ming-Kuei Lu)、(Mu-Chien Sun)、蔡崇豪(Chon-Haw Tsai)*,Polyglandular autoimmune syndrome type 4 with GAD antibody and dystonia,CLINICAL NEUROLOGY AND NEUROSURGERY,2012 ,():
SCI論文 (Chen CC)*、(Lin WY)、(Chan HL)、許怡婷(Yi-Ting Hsu(Hseu))、(Tu PH)、(Lee ST)、邱尚明(Shang-Ming CHIOU)、蔡崇豪(Chon-Haw Tsai)、(Lu CS)、(Brown P),Stimulation of the subthalamic region at 20Hz slows the development of grip force in Parkinson's disease.,EXPERIMENTAL NEUROLOGY,2011 Sep,231(1):91-96
SCI論文 許怡婷(Yi-Ting Hsu(Hseu))*、葉建治(Jiam-Jhih Ya)、蔡崇豪(Chon-Haw Tsai),A patient with superficial siderosis, intraspinal cyst,low-pressure headache and low-lying cord,ACTA NEUROLOGICA BELGICA,2011 ,2011(111):357-359
SCI論文 陳睿正(Jui-Cheng Chen)、許怡婷(Yi-Ting Hsu(Hseu))、邱尚明(Shang-Ming CHIOU)、呂明桂(Ming-Kuei Lu)、林裕欽(Yu-Chien Lin)、高嘉鴻(Chia-Hung Kao)、黃偉師(Wei-Shih Huang)、蔡崇豪(Chon-Haw Tsai)*,Cortical and Non-Cortical Myoclonus of Creutzfeldt-Jakob Disease,EUROPEAN NEUROLOGY,2010 Nov,64():265-267
SCI論文 呂明桂(Ming-Kuei Lu)、(Jung Patrick)、(Bliem Barbara)、施旭姿、許怡婷(Yi-Ting Hseu)、楊玉婉(Yu-Wan Yang)、(Ziemann Ulf)、蔡崇豪(Chon-Haw Tsai)*,The Bereitschaftspotential in essential tremor,CLINICAL NEUROPHYSIOLOGY,2010 Jan,121(4):622-630
SCI論文 陳瓊珠(Chiung Chu Chen)、許怡婷(Yi-Ting Hsu(Hseu))、(Hsiao Lung Chan, Ph.D)、邱尚明(Shang-Ming CHIOU)、(Po Hsun Tu, M.D)、(Shih Tseng Lee, M.D)、蔡崇豪(Chon-Haw Tsai)、(Chin Song Lu, M.D)、(Peter Brown, M.D.),Complexity of subthalamic 13-35 Hz oscillatory activity directly correlates with clinical impairment in patients with Parkinson's disease,EXPERIMENTAL NEUROLOGY,2010 ,.():
 
研討會論文/Conference Papers
(發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
1﹒ The Expression of CCAAT/Enhancer-Binding Protein Delta Contributes to Kainic Acid-Induced Epilepsy in Animal and Cell Models,The 4th International Taiwanese congress of Neurology & Annual Meeting of Taiwan Neurological Society,Taipei International Convention Center, Taipei, Taiwan,2023.4.14 ~ 2023.4.16,
2﹒ Kainic Acid-Induced Astrocytic CCAAT/Enhancer-Binding Protein Delta Expression Contributes to Acute Epilepsy Progression,2022 The Taiwan Society for Biochemistry and Molecular Biology Autumn Camp,新竹北埔,2022.11.4 ~ 2022.11.6,
3﹒ Optic atrophy and parkinsonism in a family associated with OPA1 mutation,MDS Virtual Congress 2020,Virtual meeting,2020.9.12 ~ 2020.9.16,
4﹒ INHERITED OPTIC ATROPHY AND PARKINSONISM IN A FAMILY ASSOCIATED WITH OPA1 AND ATP13A2 MUTATION,16TH Asian Oceanian Congress of Neurology,Seoul, Korea,2018.11.8 ~ 2018.11.11,
5﹒ Inherited neuromyotonia associated with a novel KCNQ2 mutation,International Congress of Parkinson's Disease and Movement Disorders,Hong Kong,2018.10.5 ~ 2018.10.9,
6﹒ Novel CACNA1A gene mutation in a Taiwan family with episodic ataxia type 2,International congress of Parkinson's disease and movement disorders,Hong Kong,2018.10.5 ~ 2018.10.9,
7﹒ 結核桿菌腦膜腦炎併血管炎引起之反覆缺血性腦中風,2018神經醫學聯合學術研討會,成大醫學院,2018.5.5 ~ 2018.5.6,
8﹒ Enhanced Na+-K+-2Cl- cotransporter 1 underlies motor dysfunction in Huntington’s disease,2017 Annual Meeting of the Taiwan MovementDisorder Society,International Convention Center of National Taiwan University Hospital,2017.10.14 ~ 2017.10.15,
9﹒ INHERITED NEUROMYOTONIA AS A PHENOTYPIC VARIATION ASSOCIATED WITH A NEW MUTATION IN THE KCNQ2 GENE,XXIII World Congress of Neurology,kyoto Japan,2017.9.16 ~ 2017.9.21,
10﹒ Dysregulations of GABAergic neurotransmission in a mouse model of Huntington’s disease,20Th international congress of Parkinson's disease and Movement disorders,Germany Berlin,2016.6.19 ~ 2016.6.23,
11﹒ Tremor resetting by multi-focal single and paired transcranial magnetic stimulation in Parkinson's disease and essential tremor,30th International Congress of Clinical Neurophysiology of the IFCN,Berlin,2014.3.20 ~ 2014.3.23,
12﹒ Functional connectivity of sub-thalamic and pedunculopontine rhythms in Parkinson’s disease,30th International Congress of Clinical Neurophysiology (ICCN) of the IFCN,Berlin,2014.3.20 ~ 2014.3.23,
13﹒ Compensatory transcommissure fibers in a patient with agenesis of corpus callosum,Society for Neuroscience 2012 Annual Meeting,New Orleans, LA, USA,2012.10.13 ~ 2012.10.17,
14﹒ Case Report: Intracranial Hypotension Complicated with Subdural Hemorrhage,2012年神經醫學國際聯合學術研討會,中山醫學大學,2012.3.31 ~ 2012.4.1,
15﹒ Reduced 99mTc-TRODAT-1 uptake in the striatum corresponds to the contralateral hemi-chorea associated with small-cell lung carcinoma,2012年神經學學會暨神經醫學聯合學術研討會,中山醫學大學正心樓,2012.3.31 ~ 2012.4.1,
16﹒ Dopamine dependent functional connectivity of Subthalamic and Pedunculopontine rhythms in a Parkinsonia patient,Symposium on Engineering Medicine and Biology Applications,台中金典酒店,2012.2.11 ~ 2012.2.13,
17﹒ Correlation of [99mTc]TRODAT-1 SPECT imaging with movement-related cortical potentials in Parkinson’s disease patients,3rd Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress (AOPMC),Taipei International Convention Center, Taipei, Taiwan,2011.3.25 ~ 2011.3.27,
18﹒ Cortical and non-cortical myoclonus of Creutzfeldt-Jakob disease(CJD):Precious lesson learned from a patient,29th International Congress of Clinical Neurophysiology,Kobe,2010.10.28 ~ 2010.11.2,
19﹒ Increased risk of developing depression for patients with Parkinson’s disease(PD): A retrospective cohort study,The Movement Disorder Society's (MDS) 14th International Congress of Parkinson's,Sheraton Buenos Aires Hotel and Convention Center in Buenos Aires, Argentina,2010.6.13 ~ 2010.6.17,
20﹒ Case Report :Hyperthyroidism and anti-thrombinⅢdeficiency in a case of cerebral arterial and venous thrombosis,2010年神經醫學聯合學術研討會,南台科技大學,2010.5.1 ~ 2010.5.2,
21﹒ Polyglandular Autoimmune Syndrome Presenting with Myelopathy: A case report,2009 年神經醫學聯合學術研討會,台大國際會議中心,2009.5.9 ~ 2009.5.10,
22﹒ A Patient with Recurrent Myelitis: Clinical Manifestations and MRI Findings,台灣神經醫學聯合學術研討會,成大醫學院,2008.4.26 ~ 2008.4.27,
23﹒ Simple Hand Movement Evaluated with Functional MRI in a Possible Creutzfeldt-Jakob-Disease,神經醫學聯合學術研討會,長庚大學,2007.4.7 ~ 2007.4.8,
24﹒ MRI Cortical Ribbon Sign in patients with Creutzfeldt-Jakob Disease,2006 台灣神經醫學聯合學術研討會,中國醫藥大學,2006.4.22 ~ 2006.4.23,
 
研究計畫/Research Grant
(研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
1﹒ 個別型,DMR-112-086,許怡婷(Yi-Ting Hsu),張倍禎(Jane Pei-Chen Chang)、蘇冠賓(Kuan-Pin Su),附醫院內計畫,長新冠引致精神神經及認知障礙之臨床表現-The Formosa Long COVID Multicenter Study (FOCuS研究),$200000,2022.8.1 ~ 2023.7.31
2﹒ 個別型,DMR-112-080,鄭宇凱(Yu-Kai Cheng),許怡婷(Yi-Ting Hsu),附醫院內計畫,探討迷走神經刺激術置入於頑固性癲癇病人的神經調控效果,$400000,2022.7.1 ~ 2023.7.31
3﹒ 個別型,DMR-111-104,陳冠妃(Chen, Kuan-Fei),劉詩平(Shih-Ping Liu)、許怡婷(Yi-Ting Hsu),附醫院內計畫,利用埃勒斯-丹洛斯症候群患者皮膚纖維母細胞探討COL3A1基因突變對細胞週期的影響及其機轉,$200000,2021.8.1 ~ 2022.7.31
4﹒ 個別型,DMR-111-139,劉詩平(Shih-Ping Liu),黃毓銓(Huang, Yu-Chuen)、許怡婷(Yi-Ting Hsu),附醫院內計畫,探討OPA1和ATP13A2基因突變在帕金森氏症的分子致病機轉,$400000,2021.8.1 ~ 2022.7.31
5﹒ 個別型,MOST 109-2635-B-039-001,陳冠妃,劉詩平(Shih-Ping Liu)、許怡婷(Yi-Ting Hseu)、蔡崇豪(Chon-Haw Tsai),國科會,利用人類誘導性多能幹細胞進行涎酸酵素缺乏症之治療研究,$700000,2020.8.1 ~ 2021.7.31
6﹒ 個別型,DMR-109-068,許怡婷(Yi-Ting Hseu),盧大宇(Dah-Yuu Lu),附醫院內計畫,探討細胞吞噬作用在神經退化及老化的角色並且發展治療策略,$500000,2019.8.1 ~ 2020.7.31
7﹒ 個別型,DMR-109-070,楊依倩(Yi-Chien Yang),蔡崇豪(Chon-Haw Tsai)、許怡婷(Yi-Ting Hseu),附醫院內計畫,β類澱粉蛋白與tau蛋白於預測重積癲癇預後的角色,$310000,2019.8.1 ~ 2020.7.31
8﹒ 個別型,DMR-107-068,陳冠妃(Kuan-Fei Chen),蔡崇豪(Tsai, Chon-Haw)、許怡婷(Yi-Ting Hsu)、吳東川(Wu, Dong-Chuan),附醫院內計畫,對第二型陣發性步態不穩家族進行基因診斷與功能分析,$200000,2017.8.1 ~ 2018.7.31
9﹒ 臨床試驗與研究計畫,CMUH105-REC3-028,楊玉婉(Yang, Yu-Wan),呂明桂(Lu, Ming-Kuei)、林剛旭(Lin, Kang-Hsu)、黃匯淳(Hui-Chun Huang)、蔡崇豪(Tsai, Chon-Haw)、許怡婷(Yi-Ting Hsu)、郭育呈(Yuh-Cherng Guo)、陳冠妃(Kuan-Fei Chen)、黃偉師(Huang, Wei-Shih)、陳睿正(Chen, Jui-Cheng)、唐奇峯,附醫廠商計畫,一項為期48週、觀察性、縱貫性、多中心的研究,評估以 9.5 mg/24 h/ Exelon® 10平方公分貼片(憶思能穿皮貼片10)治療輕度至中度阿茲海默症患者之有效性,$345815,2017.1.1 ~ 2017.12.31
10﹒ 臨床試驗與研究計畫,CMUH105-REC2-069,黃匯淳(Hui-Chun Huang),林剛旭(Lin, Kang-Hsu)、黃偉師(Huang, Wei-Shih)、郭育呈(Yuh-Cherng Guo)、唐奇峯、楊玉婉(Yang, Yu-Wan)、陳睿正(Chen, Jui-Cheng)、呂明桂(Lu, Ming-Kuei)、許怡婷(Yi-Ting Hsu)、陳冠妃(Kuan-Fei Chen)、蔡崇豪(Tsai, Chon-Haw),附醫廠商計畫,一項於台灣進行的多中心觀察性試驗,在16 歲(含) 以上的癲癇患者中,評估於臨床實務上以LACOSAMIDE 治療(1) 複雜性局部癲癇發作和(2) 單純性或複雜性局部癲癇發作伴有繼發性全身發作時的安全性,$388957,2017.1.1 ~ 2017.12.31
11﹒ 臨床試驗與研究計畫,CMUH103-REC1-067,楊玉婉(Yang, Yu-Wan),蔡崇豪(Tsai, Chon-Haw)、劉崇祥(Liu, Chung-Hsiang)、呂明桂(Lu, Ming-Kuei)、黃偉師(Huang, Wei-Shih)、許怡婷(Yi-Ting Hsu)、黃匯淳(Hui-Chun Huang)、林剛旭(Lin, Kang-Hsu)、郭育呈(Yuh-Cherng Guo),附醫廠商計畫,一項多中心、雙盲、安慰劑對照、隨機、平行組別之第3期研究,評估以masitinib用於患有輕度至中度阿茲海默症之患者的安全性和療效。,$1670176,2017.1.1 ~ 2017.12.31
12﹒ 個別型,MOST 104-2314-B-039 -031 -MY2,許怡婷(Yi-Ting Hsu(Hseu)),陳儀莊、蔡崇豪(Chon-Haw Tsai),國科會,透過平衡鉀/氯離子和鈉鉀/氯離子傳輸通道調節漢丁頓式舞蹈症腦部抑制性γ-丁氨基酪酸訊號,$1087000,2016.8.1 ~ 2017.7.31
13﹒ 個別型,DMR-106-074,陳冠妃(Kuan-Fei Chen),蔡崇豪(Chon-Haw Tsai)、許怡婷(Yi-Ting Hsu(Hseu)),附醫院內計畫,以次世代定序技術建立陣發性神經疾病之基因診斷工具,$200000,2016.8.1 ~ 2017.7.31
14﹒ 國家型,MOHW105-NRICM-C-104-122-001,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen)、陳睿正(Jui-Cheng Chen)、陳冠妃(Kuan-Fei Chen)、賴仲亮(Chung-Liang Lai),衛福部,「中藥品質及中醫藥輔助療效研究」計畫-後續擴充105年,$1317000,2016.4.1 ~ 2017.3.31
15﹒ 臨床試驗與研究計畫,CMUH103-REC1-067,楊玉婉(Yu-Wan Yang),蔡崇豪(Chon-Haw Tsai)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、黃偉師(Wei-Shih Huang)、許怡婷(Yi-Ting Hsu(Hseu))、黃匯淳(Hui-Chun Huang)、林剛旭(Kang-Hsu Lin)、郭育呈(Yuh-Cherng Guo),附醫廠商計畫,一項多中心、雙盲、安慰劑對照、隨機、平行組別之第3期研究,評估以masitinib用於患有輕度至中度阿茲海默症之患者的安全性和療效。,$143245,2016.1.1 ~ 2016.12.31
16﹒ 臨床試驗與研究計畫,CMUH105-REC2-069,黃匯淳(Hui-Chun Huang),林剛旭(Kang-Hsu Lin)、黃偉師(Wei-Shih Huang)、郭育呈(Yuh-Cherng Guo)、唐奇峯、楊玉婉(Yu-Wan Yang)、陳睿正(Jui-Cheng Chen)、呂明桂(Ming-Kuei Lu)、許怡婷(Yi-Ting Hsu(Hseu))、陳冠妃(Kuan-Fei Chen)、蔡崇豪(Chon-Haw Tsai),附醫廠商計畫,一項於台灣進行的多中心觀察性試驗,在16 歲(含) 以上的癲癇患者中,評估於臨床實務上以LACOSAMIDE 治療(1) 複雜性局部癲癇發作和(2) 單純性或複雜性局部癲癇發作伴有繼發性全身發作時的安全性,$22826,2016.1.1 ~ 2016.12.31
17﹒ 臨床試驗與研究計畫,CMUH105-REC3-067,楊玉婉(Yu-Wan Yang),呂明桂(Ming-Kuei Lu)、郭育呈(Yuh-Cherng Guo)、林剛旭(Kang-Hsu Lin)、黃偉師(Wei-Shih Huang)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、唐奇峯、陳睿正(Jui-Cheng Chen)、蔡崇豪(Chon-Haw Tsai)、陳冠妃(Kuan-Fei Chen),附醫廠商計畫,一個第三期、雙盲、隨機分配試驗,探討 RVT-101 附加用於已穩定接受 donepezil 治療之輕度至中度阿茲海默症患者,相較於安慰劑之療效,$348920,2016.1.1 ~ 2016.12.31
18﹒ 個別型,MOST 104-2314-B-039 -031 -MY2,許怡婷(Yi-Ting Hsu(Hseu)),陳儀莊、蔡崇豪(Chon-Haw Tsai),國科會,透過平衡鉀/氯離子和鈉鉀/氯離子傳輸通道調節漢丁頓式舞蹈症腦部抑制性γ-丁氨基酪酸訊號,$1133000,2015.8.1 ~ 2016.7.31
19﹒ 國家型,MOHW104-NRICM-C-104-112-001,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen)、陳睿正(Jui-Cheng Chen)、陳冠妃(Kuan-Fei Chen),衛福部,104年度「中藥品質及中醫藥輔助療效研究」計畫,$1500000,2015.4.1 ~ 2016.3.31
20﹒ 國家型,NRICM103-CR-01,謝慶良(Ching-Liang Hsieh),蔡崇豪(Chon-Haw Tsai)、黃偉師(Wei-Shih Huang)、劉崇祥(Chung-Hsiang Liu)、呂明桂(Ming-Kuei Lu)、徐偉成(Woei-Cherng Shyu)、楊玉婉(Yu-Wan Yang)、曾鈞宏(Chun-Hung Tseng)、黃匯淳(Hui-Chun Huang)、許怡婷(Yi-Ting Hsu(Hseu))、周立偉(Li-Wei Chou)、郭育呈(Yuh-Cherng Guo)、林昭庚(Jaung-Geng Lin)、李采娟(Tsai-Chung Li)、顏宏融(Hung-Rong Yen),衛福部,103年度中醫藥轉譯計畫「中藥複方輔助治療缺血型中風臨床療效評估委託研究計畫」,$1518000,2014.4.24 ~ 2015.3.31
21﹒ 個別型,DMR98-IRB-213,劉彥良(Yen-Liang Liu),劉彥良(Yen-Liang Liu)、蔡崇豪(Chon-Haw Tsai)、呂宗達(Chung-Ta Lu)、林裕欽(Yu-Chien Lin)、陳睿正(Jui-Cheng Chen)、許怡婷(Yi-Ting Hsu(Hseu)),,遠紅外線刺激在癲癇患者腦波變化之研究,$100000,2010.3.4 ~ 2011.3.3
22﹒ 個別型,DMR-99-176,許怡婷(Yi-Ting Hsu(Hseu)),蔡崇豪(Chon-Haw Tsai),附醫院內計畫,遺傳性肌纖維顫搐症病患之臨床表現及基因突變分析,$150000,2010.2.1 ~ 2010.12.31